[Diagnostic value of myocardial biopsy in the diagnostic algorithm in cardiomyopathies in children]
Ivan Malcić1, Drazen Jelasić, Dalibor Sarić
1Klinika za pedijatriju, Medicinski fakultet i Klinicki bolnicki centar, Rebro, Zagreb.
Insights
Myocardial biopsy analysis is crucial for diagnosing pediatric cardiomyopathies, including dilated, hypertrophic, and restrictive types. Different analytical methods aid in confirming etiology and guiding treatment for improved outcomes.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Pathology
- Diagnostic Imaging
Context:
- Primary cardiomyopathies in children present a diagnostic challenge.
- Established guidelines from WHO/ISFC provide a framework for classification.
- Early diagnosis and etiological clarification are essential for management.
Purpose:
- To underscore the significance of myocardial biopsy analysis in the diagnostic pathway for pediatric cardiomyopathies.
- To evaluate the utility of various analytical techniques in characterizing different cardiomyopathy types.
- To establish the etiological basis of primary cardiomyopathies in a pediatric cohort.
Summary:
- A study identified 121 children with cardiomyopathy: 52 dilated (DCM), 43 hypertrophic (HCM), 6 restrictive (RCM), and 11 specific types.
- Myocardial biopsies were analyzed using light microscopy, immunofluorescence, immunohistochemistry, electron microscopy, and PCR.
- Biopsy findings revealed myocarditis in DCM, confirmed histology in HCM, and identified inflammation/amyloidosis in RCM, with other specific findings like fibroelastosis and fibroma.
Impact:
- Highlights the diagnostic yield of multi-method myocardial biopsy analysis in pediatric cardiomyopathy.
- Provides etiological insights, aiding in targeted therapy and prognosis.
- Contributes to refining diagnostic algorithms for primary cardiomyopathies in children.
Abstract:
The purpose of this work was to show the importance of myocardial bioptate analysis using different methods in the diagram of diagnostic flow in primary cardiomyopathies in children. According to the guidelines of the Task Force on Cardiomyopathies of the WHO/ISFC, we identified 121 children (50 f and 71 m) as having cardiomyopathy, giving an average occurrence for all cardiomyopathies of 38.81 for each 10,000 pts examined in our outpatient clinics for paediatric cardiology. The dilated cardiomyopathy (DCM) was identified in 52 pts (42.9%), hypertrophic cardiomyopathy (HCM) in 43 pts (35.5%) and restrictive cardiomyopathy (RCM) in 6 pts (4.8%). We placed 11 pts (9.0%) in the group of specific cardiomyopathies. In nine pts (7.4%), it was impossible to classify the cardiomyopathy. Most of those with DCM had been diagnosed prior to the age of 3 years (RR 1.9, 95% CI 1.4-2.47). There were no statistically significant differences in the incidences of DCM as compared to HCM (Z 0.923, p < 0.1779), but we encountered a significantly lower occurrence of RCM (Z 6.044, p < 0.001). The biopsy of endocardium and myocardium was done to confirm the etiology of primary cardiomyopathy in 22 pts, 12 m and 10 f, age 1 to 17 (average age 9.5y). The bioptates were analysed by light microscope (Dallas criteria) in all pts, 13 bioptates by direct immunofluorescence, 8 by immunohystochemical method (two hystochemically by the method of coloring with Kongo red, one by the microscopy in polarised light), 7 by electron microscope, and 5 by PCR method where DNA and RNA of cardiotrophic viruses was used. Out of 10 pts with DCM, in 4 myonecrosis as a consequence of acute myocarditis and in 6 signs of late inflammatory processes, as a consequence of chronic immunologic myocarditis, were found. In 4 of them rebiopsy proved complete healing. In 5 pts with HCM the diagnosis was confirmed hystologically. One bioptate was analysed by electron microscope to rule out mitochondriopathy. Out of 4 pts with RCM due to inflammation, in 3 pathohistological findings proved diagnosis and in one showed primary amyloidosis. In one patient pathohystological finding showed fibroelastosis. In one patient heart tumor (fibroma) has been found.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Dysrhythmias V: Evaluating Dysrhythmias
Mitral Stenosis II: Clinical features and Diagnostic Tests


